StockData
International Flavors & Fragrances Inc logo

International Flavors & Fragrances Inc (IFF) company profile

IFFNYSEIndustrial Organic ChemicalsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/303% below fair value
$81.16+0.78 (+0.97%)

Close on Nov 13, 2026Market cap $20.71BP/E –Yield 1.97%

About International Flavors & Fragrances

Industrial Organic Chemicals, SIC 2860

International Flavors & Fragrances Inc. creates and manufactures ingredients and solutions used across food, beverage, health, biosciences, and scent applications. Operating primarily through four segments—Taste, Food Ingredients, Health & Biosciences, and Scent—the company offers flavor compounds, specialty food ingredients like plant-based proteins and natural preservatives, biotechnology-derived enzymes, probiotics, cultures, and fragrance compounds. Its offerings serve consumer-goods manufacturers producing items such as dairy, meats, beverages, snacks, dietary supplements, home cleaning products, personal care items, perfumes, and animal nutrition.

The enterprise maintains a worldwide operational footprint with approximately 170 manufacturing facilities, creative centers, and application laboratories located in about 30 countries, alongside five primary research and development centers in the United States, Denmark, and the Netherlands. The organization employs roughly 21,500 people across the globe, with approximately 5,500 based in the United States. Its principal executive offices are situated in New York, New York, and Wilmington, Delaware.

Summary of the business section of International Flavors & Fragrances's latest annual report, written by StockData.

Company profile

Company

Legal name
International Flavors & Fragrances Inc
Founded
1958
Headquarters
New York, NY
Address
521 W 57th St 10019
Phone
(212) 765-5500
Website
iff.com
Employees
21,500, Dec 31, 2025
Industry
Industrial Organic Chemicals
Incorporated in
New York
Fiscal year ends
December 31
Auditor
PricewaterhouseCoopers LLP, New York, New York

Stock & identifiers

Ticker
IFF
Exchange
NYSE
IPO date
Dec 17, 1974
Shares outstanding
255M, Jul 31, 2026
Public float
$18.85B, Jun 30, 2025
Filer category
Large accelerated filer
Stock splits
3-for-1, Jan 20, 1994
SEC CIK
51253
CUSIP
459506101
ISIN
US4595061015
FIGI
BBG000BLSL58
Share class FIGI
BBG001S5S5F7
LEI
BZLRL03D3GPGMOGFO832
EIN
13-1432060

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
J. Erik FyrwaldChief Executive Officer, Director120,966
de Mendonca Ana Paula TelesPresident, Scent0
Marc BirenkrantController & CAO9,643
Michael DeVeauEVP, CFO5,199
Ralf FinzelEVP, Global Operations Officer17,621
Deborah BorgEVP, Chief Ppl&Culture Officer37,925
Yuvraj AroraPresident, Taste & CCO17,283
Andres Roberto MullerPresident, Food Ingredients3,016
Stephen N. LandsmanEVP, General Counsel17,164
Leticia Goncalves LourencoPresident, Health & Bioscience5,983
Beril YildizCAO, SVP & Controller3,321
Angela StrzeleckiPresident, Pharma Solutions10,362
Jennifer Amy JohnsonEVP, General Counsel7,357
Simon HerriottPres. Health & Bioscience10,755
Mehmood KhanDirector7,173
Paul J. FribourgDirector2,726,339
Dawn C. WilloughbyDirector434
Cynthia T. JamisonDirector604
Jesus B. MantasDirector–
Richard MulliganDirector1,712
Kevin O'ByrneDirector26,071
Virginia DrososDirector2,434
Brett IcahnDirector34,712
Mark J. CostaDirector463
Hernandez Margarita PalauDirector2,393

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Mr Andreas Fibig
$0$0$4.36M$71$110
FY2025
Mr Erik Fyrwald
$15.00M$7.49M$4.36M$71$110
FY2025
Mr Frank Clyburn
$0$0$4.36M$71$110
FY2024
Mr Andreas Fibig
$0$0$3.59M$75$126
FY2024
Mr Erik Fyrwald
$24.15M$25.11M$3.59M$75$126
FY2024
Mr Frank Clyburn
$5.08M$339.71K$3.59M$75$126

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsIncentive payOtherTotalvs. prior year
J. Erik Fyrwald
CEO
$1.03M–$11.66M$2.05M$272.62K$15.00M-38%
Michael DeVeau
Chief Financial Officer
$700.00K–$2.33M$623.07K$58.18K$3.71M–
Leticia Gonçalves Lourenço
President, Health & Biosciences
$566.67K$1.00M$3.60M$600.37K$45.35K$5.81M–
Yuvraj Arora
President, Taste
$718.79K–$3.20M$660.90K$156.33K$4.74M+25%
Andres Muller
President, Food Ingredients
$615.75K$325.00K$2.16M$459.42K$55.13K$3.61M–
Jennifer Johnson
Former EVP, General Counsel and Corporate Secretary
$349.15K–$1.48M$266.74K$1.91M$4.00M+30%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had approximately 21,500 employees worldwide, of whom approximately 5,500 are employed in the United States.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?